Trials / Conditions / Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder (GAD)

31 registered clinical trials studyying Generalized Anxiety Disorder (GAD) — 20 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety NCT07430800	University of Southern California	N/A
Not Yet Recruiting	Text Message Safety Behavior Fading for Pathological Worry NCT07391020	Florida State University	N/A
Recruiting	Stepped Care Treatment for Anxiety Resilience NCT07228143	Andrew Wiese	N/A
Not Yet Recruiting	An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms NCT07329673	Qbtech AB	—
Recruiting	Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder NCT07123467	Wayne State University	Phase 3
Not Yet Recruiting	Therapy and Tech Study NCT07225192	University of California, Irvine	N/A
Not Yet Recruiting	Internet-Based Cognitive Behavioral Therapy With Treatment as Usual for Generalized Anxiety Disorder and Major NCT07177365	National Health Research Institutes, Taiwan	N/A
Recruiting	Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety D NCT06937892	Karolinska Institutet	N/A
Recruiting	The Effect of Patient Preference for Treatment Model in Internet Delivered Cognitive Behavior Therapy for Gene NCT07201844	Karolinska Institutet	N/A
Not Yet Recruiting	Metacognitive Therapy vs Unified Protocol for Patients With Comorbid Anxiety Disorders NCT06971692	Karolinska Institutet	N/A
Recruiting	Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children an NCT07024758	Baylor College of Medicine	N/A
Recruiting	Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilo NCT07429578	University of Sao Paulo	N/A
Recruiting	Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety NCT06969170	Queen's University	Phase 2
Recruiting	Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Th NCT06846320	AbbVie	Phase 2
Active Not Recruiting	Relief From Stress Via Social Protection in Senegal NCT06698471	Georgetown University	N/A
Enrolling By Invitation	Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric I NCT06823024	Psyrin Inc.	—
Completed	Epidemiological Study on the Prevalence of Mental Disorders in Slovakia NCT07129408	Comenius University	—
Not Yet Recruiting	Therapeutic Effect of Neuromodulation on Anxiety Disorders by High-Definition Transcranial Electrical Stimulat NCT06775145	National Taiwan University Hospital	N/A
Recruiting	EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety D NCT06811311	Uskudar University	N/A
Recruiting	LHC-CIDI-5 in Hong Kong NCT06804525	The University of Hong Kong	—
Completed	Impact of Anxiety and Depression on Implicit and Explicit Memory Performance NCT06663423	Islamic Azad University, Sanandaj	—
Enrolling By Invitation	Clinical Efficacy and Mechanism of rTMS Based on dlPFC in the Intervention of Generalized Anxiety Disorder Wit NCT06931236	Yanghua Tian	N/A
Recruiting	Targeting Social Function in Anxiety and Eating Disorders NCT06198023	University of Texas Southwestern Medical Center	N/A
Completed	Digital Versus Hybrid Interventions in Promoting Nutrition Knowledge Among Saudi Adolescent Girls NCT06836336	Umm Al-Qura University	N/A
Completed	A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, NCT06024239	AbbVie	Phase 1
Completed	Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Particip NCT05738850	AbbVie	Phase 1
Completed	Online Writing Intervention for Major Depressive Disorder NCT06699719	Centre for Addiction and Mental Health	N/A
Withdrawn	Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Generalized Anxiety NCT02708472	University of Texas Southwestern Medical Center	N/A
Completed	EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD) NCT02305797	Edgemont Pharmaceuticals, LLC	Phase 3
Completed	Clinical, Neurophysiological and Neuroendocrine Effects of Aerobe Exercise in Generalized Anxiety Disorder (GA NCT02662803	Charite University, Berlin, Germany	N/A
Completed	SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), NCT01470469	Shire	Phase 2